Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript

Acasti Pharma Inc. (NASDAQ:ACST) Q3 2023 Earnings Call Transcript February 14, 2023

Company Representatives: Jan D’Alvise – President, Chief Executive Officer Brian Ford – Chief Financial Officer Pierre Lemieux – Chief Operating and Scientific Officer, Co-Founder Prashant Kohli – Chief Commercial Officer Robert Blum – Lytham Partners

Operator: Good day, and welcome to the Acasti Pharma Reports Third Quarter of Fiscal Year 2023 Financial Results and Business Update Call. All participants will...